Home Assessment and Initiation of ART vs Clinic-based ART Assessment and Initiation: Reporting of HIV-positive Results
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.0598 | 0.0549 | 0.0651 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.0328 | 0.0292 | 0.0369 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | 0.027 | 0.0206 | 0.0334 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 1.82 | 1.58 | 2.1 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 1.87 | 1.61 | 2.18 | log | ClinicalTrials.gov | |
| Number needed to treat, for one more participant with the outcome on Home Assessment and Initiation of ART than on Clinic-based ART Assessment and Initiation | 37.1 | 29.9 | 48.5 | from the risk difference interval | ClinicalTrials.gov |
Groups 2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | Home Assessment and Initiation of ART | Optional home initiation of HIV care following HIV self-testing | 490 | 8,194 | OG000 | ClinicalTrials.gov |
| Group 2 | Clinic-based ART Assessment and Initiation | Facility-based HIV care following HIV self-testing only | 278 | 8,466 | OG001 | ClinicalTrials.gov |
Outcome 5
| Field | Value | Source |
|---|---|---|
| Type | SECONDARY | ClinicalTrials.gov |
| Title | Reporting of HIV-positive Results | ClinicalTrials.gov |
| Description | Comparison of the proportion of all cluster adults confiding HIV-positive results to the resident community counsellor between study arms during the 1-year study period | ClinicalTrials.gov |
| Time frame | The first 6-months following availability of home-based HIV testing | ClinicalTrials.gov |
| Population | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi | ClinicalTrials.gov |
| NCT number | NCT01414413 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | HIV | ClinicalTrials.gov |
| Interventions | Home assessment and initiation of ART, Clinic-based ART assessment and initiation | ClinicalTrials.gov |
| Lead sponsor | Liverpool School of Tropical Medicine | ClinicalTrials.gov |
| Results first posted | 2014-04-07 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT01414413?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.